Location via proxy:   [ UP ]  
[Report a bug]   [Manage cookies]                
Scribd Logo
Upload

Welcome to Scribd!

  • 42 views

    Lupin LTD

    Uploaded by

    Tarique Pathan
    Lupin Ltd. is an Indian pharmaceutical company headquartered in Mumbai. Its balance sheet shows sources of funds including owner's funds such as equity share capital of Rs. 88.94 crore and reserves & surplus of Rs. 2,441.61 crore, as well as loan funds including secured loans of Rs. 704 crore and unsecured loans of Rs. 202.81 crore as of March 2010. The balance sheet also shows uses of funds such as fixed assets of Rs. 1,191.39 crore, capital work in progress of Rs. 140.83 crore, investments of Rs. 724.07 crore, and net current assets of Rs. 1,381.07

    Copyright:

    Attribution Non-Commercial (BY-NC)
    Download as DOCX, PDF, TXT or read online from Scribd

    Lupin LTD

    Uploaded by

    Tarique Pathan
    42 views2 pages
    Lupin Ltd. is an Indian pharmaceutical company headquartered in Mumbai. Its balance sheet shows sources of funds including owner's funds such as equity share capital of Rs. 88.94 crore and reserves & surplus of Rs. 2,441.61 crore, as well as loan funds including secured loans of Rs. 704 crore and unsecured loans of Rs. 202.81 crore as of March 2010. The balance sheet also shows uses of funds such as fixed assets of Rs. 1,191.39 crore, capital work in progress of Rs. 140.83 crore, investments of Rs. 724.07 crore, and net current assets of Rs. 1,381.07

    Original Title

    Lupin Ltd

    Copyright

    © Attribution Non-Commercial (BY-NC)

    Available Formats

    DOCX, PDF, TXT or read online from Scribd

    Did you find this document useful?

    Is this content inappropriate?

    Lupin Ltd. is an Indian pharmaceutical company headquartered in Mumbai. Its balance sheet shows sources of funds including owner's funds such as equity share capital of Rs. 88.94 crore and reserves & surplus of Rs. 2,441.61 crore, as well as loan funds including secured loans of Rs. 704 crore and unsecured loans of Rs. 202.81 crore as of March 2010. The balance sheet also shows uses of funds such as fixed assets of Rs. 1,191.39 crore, capital work in progress of Rs. 140.83 crore, investments of Rs. 724.07 crore, and net current assets of Rs. 1,381.07

    Copyright:

    Attribution Non-Commercial (BY-NC)
    Download as DOCX, PDF, TXT or read online from Scribd
    Download as docx, pdf, or txt
    42 views2 pages

    Lupin LTD

    Uploaded by

    Tarique Pathan
    Lupin Ltd. is an Indian pharmaceutical company headquartered in Mumbai. Its balance sheet shows sources of funds including owner's funds such as equity share capital of Rs. 88.94 crore and reserves & surplus of Rs. 2,441.61 crore, as well as loan funds including secured loans of Rs. 704 crore and unsecured loans of Rs. 202.81 crore as of March 2010. The balance sheet also shows uses of funds such as fixed assets of Rs. 1,191.39 crore, capital work in progress of Rs. 140.83 crore, investments of Rs. 724.07 crore, and net current assets of Rs. 1,381.07

    Copyright:

    Attribution Non-Commercial (BY-NC)
    Download as DOCX, PDF, TXT or read online from Scribd
    Download as docx, pdf, or txt
    of 2

    Lupin Ltd.

    - Research Center
    500257  LUPIN  Group (A) BSE data
    Add to Portfolio | Watch List | Game

    Quantity
     
    Cost/Share
     
    DD MM YYYY
    Date      

    Goes above Rs  

    Goes below Rs  

    View Tips    Add to :  Portfolio  |  Watchlist  |  Game

     Back to Company Page


    Quarterly
    Results Half yearly
    Annual
    Balance sheet
    Statement P&L
    Cash flow
    Dividend
    Bonus
    More Share holding
    Capital structures
    Ratio
    (Rs crore)

    Balance sheet
      Mar ' 10 Mar ' 09 Mar ' 08 Mar ' 07 Mar ' 06
    Sources of funds
    Owner's fund
    Equity share capital 88.94 82.82 82.08 80.34 40.14
    Share application money - - - - -
      Mar ' 10 Mar ' 09 Mar ' 08 Mar ' 07 Mar ' 06
    Preference share capital - - - - -
    Reserves & surplus 2,441.61 1,292.48 1,234.97 808.07 603.81
    Loan funds
    Secured loans 704.00 565.12 560.88 390.91 428.65
    Unsecured loans 202.81 379.79 404.67 473.64 483.95
    Total 3,437.36 2,320.21 2,282.60 1,752.96 1,556.55
    Uses of funds
    Fixed assets
    Gross block 1,616.52 1,331.37 1,155.05 951.71 835.06
    Less : revaluation reserve - - - - -
    Less : accumulated depreciation 425.13 355.75 291.98 237.90 192.66
    Net block 1,191.39 975.62 863.07 713.81 642.40
    Capital work-in-progress 140.83 116.31 68.95 82.55 25.21
    Investments 724.07 473.87 292.49 5.86 9.50
    Net current assets
    Current assets, loans & advances 2,333.50 1,820.38 1,733.65 1,482.10 1,354.47
    Less : current liabilities & provisions 952.43 1,065.97 675.56 531.36 475.03
    Total net current assets 1,381.07 754.41 1,058.09 950.74 879.44
    Miscellaneous expenses not written - - - - -
    Total 3,437.36 2,320.21 2,282.60 1,752.96 1,556.55
    Notes:
    Book value of unquoted investments 724.07 473.87 290.38 3.75 7.39
    Market value of quoted investments - - 2.13 2.11 2.15
    Contingent liabilities 113.70 114.41 72.47 89.34 99.41
    Number of equity sharesoutstanding (Lacs) 889.44 828.20 820.81 803.45 401.41

    You might also like